Letters, Testimony & Comments
November 16, 2011
Given by
Russell M. Medford, MD, PhD
President and CEO, Salutria Pharmaceuticals, LLC
BIO Board Standing Committee on Bioethics Co-...
November 16 2011
July 7, 2009
July 7 2009
May 27, 2009
Re: Draft National Institutes of Health Guidelines for Human Stem Cell Research (FR Doc. E9-9313)
Dear Sir/Madam:
The Biotechnology...
May 27 2009
June 6, 2007
BIO Letter to Speaker Pelosi regard BIO's support for S. 5
June 6 2007
April 10, 2007
Letter to Senate Majority Leader Henry Reid
April 10 2007
June 16, 2006
June 16 2006
February 7, 2006
Supporting the Genetic Information Nondiscrimination Act (GINA)
February 7 2006
October 3, 2005
Dear Governor Doyle:
On behalf of the Biotechnology Industry Organization (BIO) and the Wisconsin Biotechnology and Medical Device...
October 3 2005
April 11, 2005
Testimony of the Biotechnology Industry Organization (BIO)
Before the Texas House of Representatives State Affairs Committee
Regarding...
April 11 2005
March 27, 2005
The Biotechnology Industry Organization (“BIO”) is pleased to have the opportunity to comment on the Food and Drug...
March 27 2005
March 3, 2005
Testimony of the Biotechnology Industry Organization (BIO)
Before the Maryland House Health and Government Operations Committee...
March 3 2005
March 2, 2005
Testimony of the Biotechnology Industry Organization (BIO) Before the Maryland Senate Education, Health and Environmental Affairs...
March 2 2005
November 16, 2004
To the Members of the U.N. General Assembly:
The Biotechnology Industry Organization (BIO) represents more than 1,000 biotechnology...
November 16 2004
September 27, 2004
Dear Sir/Madam:
The following comments are provided by the Biotechnology Industry Organization
(BIO). BIO represents more than 1,000...
September 27 2004
June 12, 2003
Statement of Michael J. Werner, Esq.
Vice President, Bioethics
Biotechnology Industry Organization
Before the
President's Council...
June 12 2003
May 19, 2003
Supporting legislation that prohibits genetic discrimination.
May 19 2003
April 15, 2003
Leon R. Kass, M.D., Chairman
The President's Council on Bioethics
1801 Pennsylvania Avenue, NW
Suite 800
Washington, DC 20005...
April 15 2003
February 25, 2003
February 25 2003
June 14, 2002
Dear Majority Leader Daschle:
The Biotechnology Industry Organization (BIO) opposes Senator Brownback...
June 14 2002
June 14, 2002
Dear Senator Hatch:
I read in the Washington Post that Senators are considering a two-year moratorium on...
June 14 2002
April 25, 2002
Robinsue Frohboese, Ph.D.
Acting Director, Office for Civil Rights
U.S. Department of Health and Human Services
Attention: Privacy 2,...
April 25 2002
April 23, 2002
Good morning, Mr. Chairman and Members of the Committee. My name is Dr. Charles Johnson. I am Associate Director of Specialty...
April 23 2002
April 16, 2002
April 16 2002
July 11, 2001
Written Statement of J. Craig Venter, PhD, President, Celera Genomics On Behalf of The Biotechnology Industry Organization (BIO) Before...
July 11 2001
June 20, 2001
Good afternoon. My name is Thomas Okarma. I am the President and CEO of Geron Corporation in Menlo Park, California. Geron is a...
June 20 2001
June 19, 2001
Good afternoon. My name is Thomas Okarma. I am the President and CEO of Geron Corporation in Menlo Park, California. Geron is a...
June 19 2001
May 2, 2001
Good afternoon. My name is Carl Feldbaum. I am the president of the Biotechnology Industry Organization, otherwise known as BIO. BIO...
May 2 2001
April 18, 2001
The Biotechnology Industry Organization (BIO) is pleased to submit comments to the Food and Drug Administration (FDA) on the proposed...
April 18 2001
April 18, 2001
The Biotechnology Industry Organization (BIO) is pleased to submit comments to the Food and Drug Administration (FDA) on the proposed...
April 18 2001
March 30, 2001
Summary of Testimony of Thomas Okarma, MD, PhD
BIO opposes human reproductive cloning. It is too dangerous technically and raises too...
March 30 2001
February 1, 2001
Dear Mr. President:
Recently certain groups have announced plans to clone human beings. The Biotechnology Industry Organization (BIO)...
February 1 2001
January 17, 2001
President-Elect George W. Bush
Bush-Cheney Transition Headquarters
1800 G Street, N.W.
Washington, DC 20270
Dear President-Elect...
January 17 2001
December 12, 2000
The Biotechnology Industry Organization (BIO) submits these comments on the proposal published by the National Institutes of Health (NIH...
December 12 2000
April 26, 2000
Testimony of Joanna C. Horobin, MD
Executive Vice President For Commercial Development
EntreMed Inc. on behalf of
Biotechnology...
April 26 2000
March 10, 2000
Good afternoon. My name is Michael Werner. I am bioethics counsel for the Biotechnology Industry Organization (BIO). BIO represents more...
March 10 2000
February 15, 2000
Dear Dr. Hamburg:
The Biotechnology Industry Organization ("BIO") is pleased to offer the following comments regarding...
February 15 2000
February 2, 2000
Good morning. I am Stewart Parker, CEO of Targeted Genetics Corporation, a biotechnology company based in Seattle, Washington. I am...
February 2 2000
January 31, 2000
Dear Dr. McCabe:
The Biotechnology Industry Organization (BIO) represents 850 companies, academic institutions and state biotechnology...
January 31 2000
May 27, 1999
The Biotechnology Industry Organization (BIO) is encouraged that the Subcommittee on Health and the Environment of the House Commerce...
May 27 1999
March 22, 1999
Harold Shapiro, Ph.D.
Chairman
c/o E. Randolph Hull
National Bioethics Advisory Commission
6100 Executive Blvd., Suite 5B01...
March 22 1999
January 12, 1999
EXECUTIVE SUMMARY
Pluripotent stem cells research provides the hope of a new generation of therapeutics. Using cell transplants...
January 12 1999
March 27, 1997
March 27, 1997
The Honorable William J. Clinton
President of the United States
The White House
Washington, D.C. 20500
Dear Mr....
March 27 1997
Dear Mr. Chairman:
On behalf of the Biotechnology Industry Organization (BIO), I am writing to
encourage you to consider the very...
Letters, Testimony & Comments
November 16 2011
Given by
Russell M. Medford, MD, PhD
President and CEO, Salutria Pharmaceuticals, LLC
BIO Board Standing Committee on Bioethics Co-...
May 27 2009
Re: Draft National Institutes of Health Guidelines for Human Stem Cell Research (FR Doc. E9-9313)
Dear Sir/Madam:
The Biotechnology...
June 6 2007
BIO Letter to Speaker Pelosi regard BIO's support for S. 5
April 10 2007
Letter to Senate Majority Leader Henry Reid
Press Releases
November 17 2011
WASHINGTON, D.C. (Thursday, November 17, 2011) - Russell M. Medford, MD, PhD, President and CEO of Salutria...
December 16 2010
WASHINGTON, D.C. (Thursday, December 16, 2010) - Research and development in synthetic biology is an evolution of...
September 29 2010
WASHINGTON, D.C. (Wednesday, September 29, 2010) - Biotechnology Industry Organization (BIO) President and CEO Jim...
August 24 2010
WASHINGTON, D.C. (Tuesday, August 24, 2010) - Biotechnology Industry Organization (BIO) President and CEO Jim...
May 24 2010
WASHINGTON, D.C. (Monday, May 24, 2010) - Achievement of a milestone in creating synthetic life in the form of a...
Receive our newsletter from BIOtechNOW
Business Solutions Sponsor
